Using the assay, we conducted multifaceted characterizations of anti‐BCMA and APRIL‐based CAR T cell constructs against BCMA+ and BCMA knockout (KO) multiple myeloma MM.1s tumor cells. Here, TNFRSF17 is linked to Miyoshi myopathy.